Glycorex Transplantation AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
For the nine months, sales was SEK 27.75 million compared to SEK 21.96 million a year ago. Revenue was SEK 28.98 million compared to SEK 22.84 million a year ago. Net loss was SEK 6.64 million compared to SEK 8.14 million a year ago. Basic loss per share from continuing operations was SEK 0.09 compared to SEK 0.11 a year ago.